Below, we outline some of the most notable preclinical and clinical studies related to AOD-9604's effects: In a 12-week clinical trial, participants administered 1mg/daily AOD-9604 experienced an average weight loss of 5.72lb, while the placebo group shed only 1.76lb
Due to the high polarity of -Arbutin, it readily forms hydrogen bonds to stabilize binding conformation
It is studied and sold strictly as a research compound or off-label growth-hormone-axis agent explored for muscle growth and recovery, not as an approved therapeutic or an over-the-counter supplement
T2DM patients exhibit a 3-fold higher susceptibility to tuberculosis, directly reflecting measurable functional failure of NK cells and T cells
Although the findings point to a safe and practical way to support attention, mood, and brain creatine levels during menopause , the trial was small, lasted only eight weeks, and included brain scans from just 16 participants